Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalent, Coster in pMDI Development Pact | Contract Pharma
Breaking News, Collaborations & Alliances

Catalent, Coster in pMDI Development Pact

New line will be part of Catalent's Inhalation CoE

Coster has signed an agreement with Catalent Pharma Solutions for the development of a line designed for filling pMDIs (pressurized Metered Dose Inhalers). The high-output line will be part of Catalent’s Inhalation Center of Excellence in Research Triangle Park, NC.
 
The filling line will incorporate Coster’s technology and will have a capacity of 150 cans per minute. The new line is part of Catalent’s $20 million investment at the site and expands existing capabilities. The main filling line will include camera vision systems for validation of crimping parameters using statistical analysis and Coster’s Air-Q system controlling the environment within an integrated clean room system
 
“The expansion at RTP is set for completion in the first quarter of 2015 and will at least double the capacity in the short term, to more than 20 million units annually, with the potential for much more over the long term,” said Christie Dolan, vice president and general manager of Catalent’s Development and Clinical Services business.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters